Improving antiarrhythmic therapy for patients with atrial fibrillation using common genetic variants
Improving antiarrhythmic therapy for patients with atrial fibrillation using common genetic variants
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd and British Cardiovascular Society
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd and British Cardiovascular Society
Subjects
More information
Scope and Contents
Contents
The observational cohort study by Trancado et al examines the efficacy and toxicity of flecainide for rhythm control therapy of atrial fibrillation (AF) depending on a common gene polymorphism in the SCN5A gene, histidine-558-to-arginine (H558R).1 This study demonstrates that flecainide’s performance in AF suppression efficacy and safety could be a...
Alternative Titles
Full title
Improving antiarrhythmic therapy for patients with atrial fibrillation using common genetic variants
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3147725908
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3147725908
Other Identifiers
ISSN
1355-6037,1468-201X
E-ISSN
1468-201X
DOI
10.1136/heartjnl-2024-325242
